BioMed Research International

Molecular Image-Guided Theranostic and Personalized Medicine 2013


Publishing date
13 Dec 2013
Status
Published
Submission deadline
26 Jul 2013

Lead Editor

1The Second Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, China

2Hangzhou Binjiang Hospital of Zhejiang University, Hangzhou, Zhejiang, China

3San Paul Hospital, Autonomous University of Barcelona, Barcelona, Spain

4University of Louisville Medical Center, Louisville, KY, USA

5National Institute of Radiological Sciences, Chiba, Japan


Molecular Image-Guided Theranostic and Personalized Medicine 2013

Description

Molecular image-guided therapy has been demonstrated to be effective in improving diagnosis, prognosis, planning, and monitoring of personalized medication. Molecular imaging modalities include positron emission tomography (PET), single-photon emission-computed tomography (SPECT), magnetic resonance imaging (MRI), computed tomography (CT), ultrasound (US), and optical imaging (Ramen, quantum dots, and bioluminescence). Among clinical molecular imaging modalities, radionuclide imaging technique is the most sensitive one which could provide target-specific information as well as function, pathway activities, and cell migration in the intact organism. For instance, the radiotracer could noninvasively assess diseases treatment endpoints which used to rely almost exclusively on biopsies and histopathological assays. New leads on the development of personalized theranostic (image and treat) agents would allow more accurate in the selection of patients who may respond to treatment.

This special issue will provide a platform of efficacy of personalized medication from molecular imaging technology which will have high impact on drug discovery, delivery, and development. It will become a series of special issues that focused on molecular imaging and personalized therapy. The special issue will be of interest to not only translational research scientists but also supportive staff, such as molecular biologists, imaging scientists, pharmaceutical developers, physicists, fellows, and staffs. Scientists are invited to submit papers. Potential topics include, but are not limited to:

  • Image-guided theranostic approach of diseases
  • Advances in bioimaging applications in preclinical drug discovery
  • PET/CT and SPECT/CT in disease management
  • Radiation dosimetric determination for radio theranostic agents
  • Imaging technology in drug development
  • Validation of imaging agents on new molecular targets
  • Personalized drug development from molecular imaging
  • Nonradioactive molecular imaging probes

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at http://www.hindawi.com/journals/bmri/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/bmri/molecular.imaging/mim13/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2014
  • - Article ID 682527
  • - Editorial

Molecular Image-Guided Theranostic and Personalized Medicine 2013

Hong Zhang | Mei Tian | ... | Yasuhisa Fujibayashi
  • Special Issue
  • - Volume 2014
  • - Article ID 759514
  • - Review Article

Molecular Imaging in Stem Cell Therapy for Spinal Cord Injury

Fahuan Song | Mei Tian | Hong Zhang
  • Special Issue
  • - Volume 2013
  • - Article ID 404361
  • - Review Article

Acoustic Droplet Vaporization in Biology and Medicine

Chung-Yin Lin | William G. Pitt
  • Special Issue
  • - Volume 2013
  • - Article ID 839683
  • - Review Article

Microfluidics for Synthesis of Peptide-Based PET Tracers

Yang Liu | Mei Tian | Hong Zhang
  • Special Issue
  • - Volume 2013
  • - Article ID 694075
  • - Clinical Study

Abacus Training Modulates the Neural Correlates of Exact and Approximate Calculations in Chinese Children: An fMRI Study

Fenglei Du | Feiyan Chen | ... | Hong Zhang
  • Special Issue
  • - Volume 2013
  • - Article ID 683768
  • - Research Article

Changes of Regulatory T and B Cells in Patients with Papillary Thyroid Carcinoma after 131I Radioablation: A Preliminary Study

Lei Jiang | Yanxia Zhan | ... | Hongcheng Shi
  • Special Issue
  • - Volume 2013
  • - Article ID 275805
  • - Review Article

The Predictive Value of Interim and Final [18F] Fluorodeoxyglucose Positron Emission Tomography after Rituximab-Chemotherapy in the Treatment of Non-Hodgkin's Lymphoma: A Meta-Analysis

Yuyuan Zhu | Jianda Lu | ... | Gang Huang
  • Special Issue
  • - Volume 2013
  • - Article ID 145427
  • - Clinical Study

Comparison of 99mTc-N-DBODC5 and 99mTc-MIBI of Myocardial Perfusion Imaging for Diagnosis of Coronary Artery Disease

Haiyan Ma | Sijin Li | ... | Xiaoshan Guo
  • Special Issue
  • - Volume 2013
  • - Article ID 759057
  • - Research Article

Molecular Imaging of Hepatocellular Carcinoma Xenografts with Epidermal Growth Factor Receptor Targeted Affibody Probes

Ping Zhao | Xiaoyang Yang | ... | Zhen Cheng
BioMed Research International
 Journal metrics
See full report
Acceptance rate8%
Submission to final decision110 days
Acceptance to publication24 days
CiteScore5.300
Journal Citation Indicator-
Impact Factor-
 Submit Check your manuscript for errors before submitting

Article of the Year Award: Impactful research contributions of 2022, as selected by our Chief Editors. Discover the winning articles.